35.94
4.23%
1.46
시간 외 거래:
36.39
0.45
+1.25%
전일 마감가:
$34.48
열려 있는:
$34.58
하루 거래량:
952.26K
Relative Volume:
0.85
시가총액:
$3.37B
수익:
-
순이익/손실:
$-115.88M
주가수익비율:
-26.82
EPS:
-1.34
순현금흐름:
$-104.72M
1주 성능:
+4.33%
1개월 성능:
+26.55%
6개월 성능:
+84.12%
1년 성능:
+433.23%
엣지와이즈 Stock (EWTX) Company Profile
명칭
Edgewise Therapeutics Inc
전화
720-262-7002
주소
1715 38TH ST, BOULDER
엣지와이즈 Stock (EWTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-05-01 | 개시 | Truist | Buy |
2022-08-25 | 다운그레이드 | Goldman | Neutral → Sell |
2022-04-13 | 개시 | RBC Capital Mkts | Outperform |
2022-01-28 | 개시 | Goldman | Neutral |
엣지와이즈 주식(EWTX)의 최신 뉴스
abrdn plc Purchases Shares of 256,645 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics shares maintain price target on positive data By Investing.com - Investing.com Australia
Novo Holdings A S Sells 794,530 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Moody Aldrich Partners LLC Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics stock hits 52-week high at $35.34 - Investing.com
Edgewise Therapeutics stock hits 52-week high at $35.34 By Investing.com - Investing.com Canada
Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 32.99, Up 3.68 - The Dwinnex
Top investors say Edgewise Therapeutics Inc (EWTX) ticks everything they need - SETE News
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week HighShould You Buy? - MarketBeat
Is it possible to buy Edgewise Therapeutics Inc(EWTX) shares at a good price now? - US Post News
EWTX (Edgewise Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
SG Americas Securities LLC Sells 34,544 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Piper Sandler Increases Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $51.00 - Defense World
Minimal stock impact anticipated for Edgewise Therapeutics stock even with potential CK miss - Investing.com Canada
Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 4.5% Following Analyst Upgrade - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $51.00 at Piper Sandler - MarketBeat
(EWTX) Technical Pivots with Risk Controls - Stock Traders Daily
Edgewise Therapeutics Inc (EWTX) Stock: Navigating Drops and Gains - The InvestChronicle
Chief Scientific Officer Russell Alan J sold 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily
Edgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month HighTime to Buy? - MarketBeat
A look into Edgewise Therapeutics Inc (EWTX)’s deeper side - SETE News
Financial Analysis: Edgewise Therapeutics Inc (EWTX)’s Ratios Unveil Key Insights - The Dwinnex
Was there any good news for Edgewise Therapeutics Inc (EWTX) stock in the last session? - US Post News
Dimensional Fund Advisors LP Buys 168,219 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy Now - Yahoo Finance
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down – Here’s What Happened - Defense World
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's What Happened - MarketBeat
Edgewise Therapeutics Inc [EWTX] Insider Activity: An Update for Investors - Knox Daily
Squarepoint Ops LLC Purchases 27,687 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Millennium Management LLC Purchases 613,251 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% HigherStill a Buy? - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% Higher – Still a Buy? - Defense World
Hypertrophic Cardiomyopathy Market Expected to Experience - openPR
Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart
Edgewise Therapeutics Insiders Sold US$2.6m Of Shares Suggesting Hesitancy - Simply Wall St
Chief Scientific Officer Russell Alan J sale 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily
Marshall Wace LLP Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Dark Forest Capital Management LP Makes New $193,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society - StockTitan
Marshall Wace LLP Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Balance Sheet Breakdown: Edgewise Therapeutics Inc (EWTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
How did Edgewise Therapeutics Inc (EWTX) fare last session? - US Post News
The Potential Rise in the Price of Edgewise Therapeutics Inc (EWTX) following insiders activity - Knox Daily
Novo Holdings A S Makes New $114.26 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Frazier Life Sciences Management L.P. Buys 427,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Frazier Life Sciences Management L.P. Acquires 427,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Duchenne Muscular Dystrophy Treatment Drugs, Clinical Trials, Pipeline Insights and Companies 2024 - The Globe and Mail
Analyst Think There's Still Time to Get in on Edgewise, Up 332% - sharewise
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - Benzinga
Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 25.92, Down -2.15 - The Dwinnex
Analysts Think There's Still Time to Get in on Edgewise, Up 332% - MarketBeat
엣지와이즈 (EWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엣지와이즈 주식 (EWTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Russell Alan J | Chief Scientific Officer |
Sep 20 '24 |
Option Exercise |
0.18 |
75,000 |
13,500 |
87,719 |
Russell Alan J | Chief Scientific Officer |
Sep 20 '24 |
Sale |
28.27 |
75,000 |
2,120,101 |
12,719 |
MOORE JOHN R | General Counsel |
Sep 20 '24 |
Option Exercise |
0.71 |
50,000 |
35,500 |
53,252 |
MOORE JOHN R | General Counsel |
Sep 23 '24 |
Option Exercise |
0.71 |
20,922 |
14,855 |
24,174 |
MOORE JOHN R | General Counsel |
Sep 20 '24 |
Sale |
28.37 |
50,000 |
1,418,510 |
3,252 |
MOORE JOHN R | General Counsel |
Sep 23 '24 |
Sale |
27.63 |
20,922 |
578,064 |
3,252 |
Donovan Joanne M. | CMO |
Sep 20 '24 |
Sale |
28.29 |
7,162 |
202,603 |
14,538 |
Derakhshan Behrad | Chief Business Officer |
Sep 20 '24 |
Option Exercise |
1.93 |
42,068 |
81,191 |
57,189 |
Derakhshan Behrad | Chief Business Officer |
Sep 20 '24 |
Sale |
29.03 |
42,068 |
1,221,133 |
15,121 |
Carruthers R Michael | Chief Financial Officer |
Sep 20 '24 |
Option Exercise |
1.93 |
96,068 |
185,411 |
81,996 |
자본화:
|
볼륨(24시간):